Company Overview
Snapshot
Founded in January 2020 by Dr. Aaron Mazin, Maxim Mikhaylov, Adv. Simeon Saharov, and Dr. Yehoshua Maor, NARANHAY operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing proprietary antimicrobial solutions.
Business overview
NARANHAY is an advanced antimicrobial biotechnology company specializing in developing localized formulations to target pathogenic biofilms and microbial drivers of chronic inflammation. Its platform utilizes a mechanism-focused R&D approach to reduce biological risk through localized intervention, avoiding systemic exposure. The company's initial development programs are focused on gingival inflammation linked to Porphyromonas gingivalis and antimicrobial resistance contexts, including Staphylococcus aureus (MRSA). NARANHAY's technology is designed for multi-segment application across oral care, preventive health, hygiene, and medical device-adjacent use cases, serving both consumer and clinical pathways within the Health Tech & Life Sciences sector.
Log in to access full profile ›Company Intelligence Q&A
- What is NARANHAY's primary focus?
- NARANHAY is an advanced antimicrobial biotechnology company developing proprietary, localized formulations to target pathogenic biofilms and microbial drivers of chronic inflammation.
- When was NARANHAY founded and by whom?
- NARANHAY was founded in January 2020 by Dr. Aaron Mazin, Maxim Mikhaylov, Adv. Simeon Saharov, and Dr. Yehoshua Maor.
- What specific health issues does NARANHAY's technology address?
- NARANHAY's initial development programs focus on gingival inflammation associated with Porphyromonas gingivalis and antimicrobial resistance contexts, including Staphylococcus aureus (MRSA).
- What markets does NARANHAY's technology target?
- NARANHAY's technology is designed for multi-segment application across oral care, preventive health, hygiene, and medical device-adjacent use cases, supporting both consumer and clinical pathways.
- What is NARANHAY's current product development stage?
- NARANHAY is currently in the R&D product stage, focusing on developing its advanced antimicrobial solutions.